Financhill
Back

Moleculin Biotech Stock Predictions

Moleculin Biotech Stock Forecast

  • Is Moleculin Biotech Stock Undervalued?
    The current Moleculin Biotech [MBRX] share price is $2.50. The Score for MBRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • MBRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Moleculin Biotech Stock Go Up Next Year?

Data Unavailable

Moleculin Biotech Stock Rating

Data Unavailable

Moleculin Biotech Stock Price History

Is MBRX stock going to rise?

  • The current trend is relatively stagnant and MBRX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moleculin.com

52-Week Data

52-Week High:
15.75
52-Week Low:
2.12

Prediction Charts

Market Cap:
7.11M
Price in USD:
2.50
Volume:
29.94K
Beta:
1.89

Technical Analysis

SMA50:
2.50
SMA100:
2.80
SMA200:
4.43
52-Wk Change:
-71.07%

Stock Predictions

  • Is Moleculin Biotech stock public?
    Yes, Moleculin Biotech is a publicly traded company.
  • What is the Moleculin Biotech stock quote today?
    The Moleculin Biotech stock price is 2.50 USD today.
  • How to buy Moleculin Biotech stock online?
    You can buy Moleculin Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 2.55 2.58 2.70 2.55
Oct-28 2.79 2.62 2.79 2.57
Oct-29 2.60 2.62 2.71 2.50
Oct-30 2.57 2.54 2.66 2.51
Oct-31 2.57 2.60 2.65 2.54
Nov-1 2.56 2.45 2.65 2.40
Nov-4 2.65 2.45 2.65 2.36
Nov-5 2.41 2.44 2.46 2.37
Nov-6 2.36 2.30 2.52 2.30
Nov-7 2.32 2.34 2.44 2.29
Nov-8 2.38 2.55 2.56 2.35
Nov-11 2.54 2.51 2.55 2.44
Nov-12 2.58 2.64 2.73 2.54
Nov-13 2.51 2.50 2.63 2.50

Moleculin Biotech Earnings

Data Unavailable

Moleculin Biotech Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.

* Moleculin Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.